ADVB
Advanced Biomed, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$4.16
+4.52%Latest reported
- Last report date
- Oct 13, 2026
- EPS actual
- -$0.26
- EPS estimate
- —
- Revenue actual
- $4.0K
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 13, 2026 | — | -$0.26 | — | $4.0K |
| May 15, 2026 | — | -$0.38 | — | — |
| Feb 13, 2026 | — | $0.32 | — | — |
| Nov 19, 2025 | — | -$0.02 | — | — |
| May 15, 2025 | — | -$0.07 | — | — |
| Sep 30, 2024 | — | -$0.01 | — | — |
| Jun 30, 2024 | — | -$0.93 | — | — |
| Mar 31, 2024 | — | -$0.04 | — | — |
| Dec 31, 2023 | — | -$0.00 | — | — |
| Sep 30, 2023 | — | -$0.02 | — | — |
| Jun 30, 2023 | — | -$0.05 | — | — |
| Mar 31, 2023 | — | -$0.02 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 13, 2026